Stockreport

Coloplast targets 8%-9% organic growth for FY 2025 amid Kerecis expansion and new launches [Seeking Alpha]

COLOPLAST AS SP/ADR  (CLPBY) 
NASDAQ:AMEX Investor Relations: coloplast.com/investor-relations
PDF Coloplast targets 8%-9% organic growth for FY 2025 amid Kerecis expansion and new launches [Read more]